plumbagin has been researched along with Anterior Choroidal Artery Infarction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arumugam, TV; Camandola, S; Cutler, RG; Greig, NH; Johnson, DA; Johnson, JA; Luo, W; Mattson, MP; Moore, TA; Mughal, MR; Son, TG; Telljohann, RS; Yu, QS | 1 |
1 other study(ies) available for plumbagin and Anterior Choroidal Artery Infarction
Article | Year |
---|---|
Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia.
Topics: Animals; Cell Line, Tumor; Cell Survival; Cells, Cultured; Cerebral Cortex; Cerebral Infarction; Disease Models, Animal; Embryo, Mammalian; Gene Expression Regulation; Glucose; Heme Oxygenase-1; Humans; Hypoxia; Infarction, Middle Cerebral Artery; Mice; Mice, Inbred C57BL; Naphthoquinones; Neuroblastoma; Neurologic Examination; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Sprague-Dawley; Transcription Factor AP-1; Transfection | 2010 |